Production (Stage)
BioAtla, Inc.
BCAB
$0.391
$0.00140.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 48.11% | 43.48% | 34.06% | 10.28% | -8.70% |
| Total Depreciation and Amortization | -25.68% | -24.24% | -7.47% | -6.27% | -0.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -54.39% | -40.10% | -32.02% | -23.16% | -15.98% |
| Change in Net Operating Assets | 69.04% | -339.29% | -238.11% | -354.26% | -205.65% |
| Cash from Operations | 48.84% | 30.84% | 13.58% | -12.80% | -27.58% |
| Capital Expenditure | -- | -- | 93.39% | 78.57% | 84.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 93.39% | 78.57% | 84.26% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,744.35% | 2,744.35% | -99.37% | -99.34% | -99.46% |
| Repurchase of Common Stock | 60.26% | 82.24% | 81.73% | 74.40% | 66.74% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,971.67% | 12,251.95% | -99.49% | -99.53% | -99.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 56.93% | 40.00% | -130.10% | -218.57% | -319.05% |